Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family (Hsp40) member B12 (DNAJB12) is a host chaperone protein located in the endoplasmic reticulum (ER) membrane that has been identified as the primary target for nucleic acid polymers (NAPs) in the treatment of chronic hepatitis B (HBV) and hepatitis D (HDV) infections (3.1.1, 3.2.2). It functions as a co-chaperone, assisting Hsp70 in the folding and assembly of transmembrane proteins and participating in endoplasmic reticulum-associated degradation (ERAD) (3.3.2). In HBV-infected cells, DNAJB12 is essential for the morphogenesis and secretion of subviral particles (SVPs), which are non-infectious particles produced in massive excess to decoy the host immune system (3.1.3, 3.2.1). NAPs like REP 2139 and REP 2165 bind to an exposed hydrophobic surface on the amphipathic alpha-helix of the DNAJB12 J-domain, preventing its interaction with Hsp70 and the proper folding of nascent Hepatitis B surface antigen (HBsAg) (3.2.3, 3.3.1). This leads to the intracellular degradation of HBsAg and a rapid decline in circulating HBsAg levels, which is thought to relieve immune exhaustion and facilitate a functional cure (2.2.1, 3.2.4).
Inhibition of subviral particle assembly and secretion by binding to an exposed hydrophobic surface (amphipathic alpha-helix) of the host chaperone DNAJB12, leading to the degradation of nascent HBsAg.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family (Hsp40) member B12 (DNAJB12) (DNAJB12).